LogicBio Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2017 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2021.
  • LogicBio Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$5.74M, a 42.2% increase year-over-year.
  • LogicBio Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$25.9M, a 29.3% increase year-over-year.
  • LogicBio Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$39M, a 23.7% decline from 2020.
  • LogicBio Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$31.5M, a 23.2% increase from 2019.
  • LogicBio Therapeutics, Inc. annual Operating Income (Loss) for 2019 was -$41M, a 129% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$39M -$7.47M -23.7% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-04
2020 -$31.5M +$9.53M +23.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-04
2019 -$41M -$23.1M -129% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 -$17.9M -$12.1M -207% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$5.85M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.